He was born with a deadly mutation. Delivered five weeks early to start gene therapy at SickKids, his progress is offering new hope21. Dezember 2025
Israel’s famed VC Jon Medved, diagnosed with ALS, backed the tech that will improve his life 21. Dezember 2025
News Hepta Raises $6.7M to Take Liquid Biopsy Beyond CancerHealthradar11. November 2025 What You Should Know: – Hepta, a biotechnology company focused on diagnosing chronic disease, has emerged from stealth announcing $6.7M…
